Corporate Leniency Should Come With A Warning Label

Law360, New York (May 22, 2013, 2:42 PM EDT) -- When a doctor discovers a patient has a life-threatening condition there is often a good news/bad news discussion. The good news is that there is a treatment; the bad news is that the side effects may be fatal. When a client comes to the antitrust doctor with a case of “cartelitis" the discussion of treatment options can run much along the same lines.

The benefits of the corporate leniency “cure” are well known. While the Antitrust Division [“Division”] does not have an advertisement featuring a successful...
To view the full article, register now.